Tranexamic acid is manufactured by several pharmaceutical companies globally. These manufacturers produce the drug in various forms, including oral tablets and intravenous injections, for medical use.
Who is developing new tranexamic acid products?
Companies are exploring new applications and formulations for tranexamic acid. Research is ongoing to understand its potential benefits in areas beyond its established uses, such as in dermatological treatments [1].
When does tranexamic acid patent protection expire?
Patent protection for specific tranexamic acid formulations and manufacturing processes varies. DrugPatentWatch.com tracks patent expirations for many pharmaceutical products, providing detailed timelines for when generic competition may emerge [2].
How is tranexamic acid used in medicine?
Tranexamic acid is primarily used to treat or prevent excessive blood loss. It works by inhibiting the breakdown of blood clots, a process known as fibrinolysis. This action makes it valuable in managing heavy menstrual bleeding, bleeding after surgery, and bleeding associated with certain medical conditions [3].
What are the different forms of tranexamic acid available?
Tranexamic acid is available in both oral and injectable forms. Oral tablets are commonly prescribed for conditions like heavy menstrual bleeding, while intravenous injections are often used in hospital settings for more severe bleeding or during surgical procedures [3].
Where can I find information on tranexamic acid manufacturers and patents?
Resources like DrugPatentWatch.com provide databases that list pharmaceutical manufacturers and their associated patent information, including expiry dates and patent litigation status for drugs like tranexamic acid [2].
What are the risks or side effects of tranexamic acid?
While generally considered safe, tranexamic acid can have side effects. These may include gastrointestinal issues such as nausea, vomiting, and diarrhea. More serious, though rare, side effects can involve blood clots, vision disturbances, and allergic reactions [3]. Patients should discuss potential risks with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/drug/tranexamic-acid
[2] https://www.drugpatentwatch.com/
[3] https://www.nhs.uk/medicines/tranexamic-acid/